Antibiotics can improve CTCL

Author(s):
Vermeer, M.H. (0000-0002-5872-4613)
Published
2019
Publication type
Article / Letter to editor

Abstract

In this issue of Blood, Lindahl et al report that aggressive antibiotic treatment inhibits disease activity and lymphocyte proliferation in cutaneous T-cell lymphoma (CTCL).(1) These results are significant because they provide further evidence for a potential link between bacterial infection, activation of the immune system, and CTCL progression as well as a rationale for aggressive antibiotic treatment as adjuvant therapy in CTCL.

Date issued
2019-09-26
Language
English
Publisher
AMER SOC HEMATOLOGY
Is part of
Blood (2019), Vol. 134, no. 13, p. 1000-1001
hdl
1887/123007
doi
10.1182/blood.2019002236